news

CLO Launches Marvelous Designer for Linux, Expanding Support for Professional Pipelines

NEW YORK, Sept. 25, 2025 /PRNewswire/ -- CLO Virtual Fashion, a global leader in digital garment simulation and the creator…

7 months ago

HashiCorp Previews the Future of Agentic Infrastructure Automation with Project infragraph

New Infrastructure and Security Lifecycle capabilities simplify hybrid operations and help move toward intelligent infrastructure operations SAN FRANCISCO, Sept. 25,…

7 months ago

Databricks and OpenAI Launch Groundbreaking Partnership to Bring Frontier Intelligence to Enterprises with Databricks Agent Bricks

$100 Million Partnership Brings OpenAI Models Natively to 20,000+ Customers on the Databricks Data Intelligence Platform SAN FRANCISCO, Sept. 25, 2025…

7 months ago

Phemex Revamps Blog to Deliver Deeper Insights and Enhanced Reader Experience

APIA, Samoa, Sept. 25, 2025 /PRNewswire/ -- Phemex, the most efficient crypto exchange, has launched a fully redesigned Phemex Blog aimed…

7 months ago

NAR India Appoints UCO as Exclusive MLS Implementer to Transform Indian Real Estate and Unlock Global Opportunities

Agreement paves the way for an empowered real estate ecosystem across India ALTAMONTE SPRINGS, Fla., Sept. 25, 2025 /PRNewswire/ --…

7 months ago

Firoz Cyrus Mistry, Santosh Nayar join Afcons Board

Induction follows Pallon S Mistry's entry last month; signals next-gen Shapoorji Pallonji family's involvement in Afcons MUMBAI, India, Sept. 25,…

7 months ago

Kia advances EV Mobility experience with new Plug and Charge Technology

Kia Plug & Charge technology for seamless EV charging at compatible stations is coming soon1Available on eligible Kia 2026 EV9…

7 months ago

Lamborghini Diablo: celebrating 35 years of an icon

Symbol of the 1990s, it elevated the concept of the super sports car thanks to its timeless design, outstanding performance,…

7 months ago

Medicenna Announces Results of Annual Meeting of Shareholders

TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage…

7 months ago

Organogenesis Provides Update on Second Phase 3 ReNu Study

Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain…

7 months ago